Engalla, Baby Boy .
HRN: 27-56-23 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2025
AMPICILLIN 250MG (VIAL)
07/29/2025
08/04/2025
IVT
150mg
Q12
Sepsis
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: